185 related articles for article (PubMed ID: 33164723)
1. Economic value of nonsurgical weight loss in adults with obesity.
Ding Y; Fan X; Blanchette CM; Smolarz BG; Weng W; Ramasamy A
J Manag Care Spec Pharm; 2021 Jan; 27(1):37-50. PubMed ID: 33164723
[No Abstract] [Full Text] [Related]
2. Economic outcomes of antiobesity medication use among adults in the United States: A retrospective cohort study.
Watkins S; Toliver JC; Kim N; Whitmire S; Garvey WT
J Manag Care Spec Pharm; 2022 Oct; 28(10):1066-1079. PubMed ID: 35856489
[No Abstract] [Full Text] [Related]
3. Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study.
Divino V; Ramasamy A; Anupindi VR; Eriksen KT; Olsen AH; DeKoven M; Meincke HH
J Manag Care Spec Pharm; 2021 Feb; 27(2):210-222. PubMed ID: 33307936
[No Abstract] [Full Text] [Related]
4. Effect of Weight Change on Economic Outcomes Among Persons with Type 2 Diabetes Mellitus in the United States: Beyond Glycemic Control.
Karkare S; Fridman M; Dang-Tan T; Lu J; Smolarz BG; DeKoven M; Iyer NN
J Manag Care Spec Pharm; 2019 Jun; 25(6):658-668. PubMed ID: 30730232
[TBL] [Abstract][Full Text] [Related]
5. Direct medical costs of obesity in the United States and the most populous states.
Cawley J; Biener A; Meyerhoefer C; Ding Y; Zvenyach T; Smolarz BG; Ramasamy A
J Manag Care Spec Pharm; 2021 Mar; 27(3):354-366. PubMed ID: 33470881
[No Abstract] [Full Text] [Related]
6. Productivity loss outcomes and costs among patients with cholangiocarcinoma in the United States: an economic evaluation.
Parasuraman S; Thiel E; Park J; Teschemaker A
J Med Econ; 2023; 26(1):454-462. PubMed ID: 36883994
[TBL] [Abstract][Full Text] [Related]
7. Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.
Yu AP; Wu EQ; Birnbaum HG; Emani S; Fay M; Pohl G; Wintle M; Yang E; Oglesby A
Curr Med Res Opin; 2007 Sep; 23(9):2157-69. PubMed ID: 17669232
[TBL] [Abstract][Full Text] [Related]
8. Health care resource utilization and costs among patients with multiple myeloma with exposure to double-class or triple-class multiple myeloma treatments: A retrospective US claims database analysis.
Yang J; Boytsov N; Carlson JJ; Barthold D
J Manag Care Spec Pharm; 2023 Aug; 29(8):917-926. PubMed ID: 37523320
[No Abstract] [Full Text] [Related]
9. Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States.
Kim N; Wang J; Burudpakdee C; Song Y; Ramasamy A; Xie Y; Sun R; Kumar N; Wu EQ; Sullivan SD
J Manag Care Spec Pharm; 2022 Jul; 28(7):740-752. PubMed ID: 35737858
[No Abstract] [Full Text] [Related]
10. Influence of body mass index on prescribing costs and potential cost savings of a weight management programme in primary care.
Counterweight Project Team
J Health Serv Res Policy; 2008 Jul; 13(3):158-66. PubMed ID: 18573765
[TBL] [Abstract][Full Text] [Related]
11. Health care resource utilization and costs associated with treatment among patients initiating calcitonin gene-related peptide inhibitors vs other preventive migraine treatments in the United States.
Varnado OJ; Manjelievskaia J; Ye W; Perry A; Schuh K; Wenzel R
J Manag Care Spec Pharm; 2022 Aug; 28(8):818-829. PubMed ID: 35876297
[No Abstract] [Full Text] [Related]
12. Association between body mass index, weight loss and the chance of pregnancy in women with polycystic ovary syndrome and overweight or obesity: a retrospective cohort study in the UK.
Haase CL; Varbo A; Laursen PN; Schnecke V; Balen AH
Hum Reprod; 2023 Mar; 38(3):471-481. PubMed ID: 36637246
[TBL] [Abstract][Full Text] [Related]
13. Impact of bariatric surgery on health care costs of obese persons: a 6-year follow-up of surgical and comparison cohorts using health plan data.
Weiner JP; Goodwin SM; Chang HY; Bolen SD; Richards TM; Johns RA; Momin SR; Clark JM
JAMA Surg; 2013 Jun; 148(6):555-62. PubMed ID: 23426865
[TBL] [Abstract][Full Text] [Related]
14. Bariatric Surgery and Long-term Durability of Weight Loss.
Maciejewski ML; Arterburn DE; Van Scoyoc L; Smith VA; Yancy WS; Weidenbacher HJ; Livingston EH; Olsen MK
JAMA Surg; 2016 Nov; 151(11):1046-1055. PubMed ID: 27579793
[TBL] [Abstract][Full Text] [Related]
15. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
[TBL] [Abstract][Full Text] [Related]
18. Health care resource utilization and costs among adult patients with hemophilia A on factor VIII prophylaxis: an administrative claims analysis.
Croteau SE; Cook K; Sheikh L; Chawla A; Sammon J; Solari P; Kim B; Hinds D; Thornburg CD
J Manag Care Spec Pharm; 2021 Mar; 27(3):316-326. PubMed ID: 33645244
[No Abstract] [Full Text] [Related]
19. Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status.
Cawley J; Meyerhoefer C; Biener A; Hammer M; Wintfeld N
Pharmacoeconomics; 2015 Jul; 33(7):707-22. PubMed ID: 25381647
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
